图书简介

Section 1: Physiology of Cardiovascular response to exercise and cardiac remodelling; 1.1 - Cardiovascular induced by exercise; 1.1.1 Sanjay Sharma and Andrew D’Silva: Physiology of exercise; 1.2 - Long term adaptation to exercise: athlete’s heart and vascular adaptations; 1.2.1 Stefano Caselli and Antonio Pelliccia: Structural and functional adaptations in the athlete’s heart; 1.2.2 Nabeel Sheikh: Impact of sporting discipline, gender, ethnicity and genetics on the athlete’s heart; 1.2.3 Graham Stuart and Guido E Pieles: The athlete’s heart in children and adolescents; 1.2.4 Stephan Gielen, M. Harold Laughlin, and Dirk J. Duncker: The vascular remodelling; Section 2: Clinical evaluation of the athlete’s heart; 2.1 - History and physical examination; 2.1.1 Maurizio Schiavon, Domenico Corrado, and Alessandro Zorzi: History and physical examination; 2.2 - The electrocardiogram in the athlete; 2.2.1 Alessandro Zorzi and Domenico Corrado: The electrocardiogram in the athlete; 2.2.2 Ricardo Stein and Victor Froelicher: Common ECG patterns of the athlete’s heart; 2.2.3 Michael Papadakis and Harshil Dhutia: Overlap ECG patterns in athlete’s heart and cardiomyopathies; Section 3: Additional testing in the evaluation of the athlete’s heart; 3.1 - Exercise testing; 3.1.1 Paolo Emilio Adami and Marco Guazzi: Protocols of exercise testing in athletes and cardiopulmonary testing: assessment of the fitness; 3.1.2 Francois Carre and Frederic Schnell: Evaluation of ischemia, blood pressure, QT interval and arrhythmias; 3.2 - Arrythmias registration; 3.2.1 Mahdi Sareban and Josef Niebauer: Ambulatory (24-h Holter monitoring, event recorders) and signal-averaged ECG for arrhythmia registration in the athlete’s heart; 3.2.2 Matthias Antz: Class-1 anti arrythmic drug provocation test; 3.2.3 Matthias Antz: Electrophysiological study; 3.3 - Imaging of the athlete’s heart: anatomical and functional; 3.3.1 Stefano Caselli and Flavio D’Ascenzi: Echocardiogram: morphologic and functional evaluation including new echocardiographic techniques; 3.3.2 Guido Claessen and Andre La Gerche: Cardiac Magnetic Resonance Imaging; 3.3.3 Stephan Mohlenkamp: Coronary computed tomography; 3.3.4 Stephan Mohlenkamp: Nuclear imaging; 3.3.5 Stephan Mohlenkamp: Coronary angiography; 3.4 - Genotyping; 3.4.1 Silvia Priori: Indications for genetic testing in athletes and its application in daily practice; Section 4: Cardiac diseases of interest in sports cardiology; 4.1 - Myocardial and coronary diseases; 4.1.1 Sanjay Sharma and Aneil Malhotra: Hypertrophic Cardiomyopathy in Athletes; 4.1.2 Gaetano Thiene, Kalliopi Pilichou, and Cristina Basso: Arrhythmogenic Cardiomyopathy and Sudden Death in Young Athletes: Causes, Pathophysiology and Clinical features; 4.1.3 Martin Halle: Myocarditis in athletes; 4.1.4 Andrew D’Silva and Sanjay Sharma: Differentiating Athlete’s Heart from Left Ventricular Noncompaction Cardiomyopathy; 4.1.5 Cristina Basso, Carla Frescura, and Gaetano Thiene: Congenital coronary artery anomalies; 4.2 - Valvular and aortic disease; 4.2.1 Christian Schmied and Sanjay Sharma: Mitral Valve Prolapse in Relation to Sport; 4.2.2 Natesa Pandian and Benjamin S. Wessler: Bicuspid Aortic Valve Disease and Competitive Sports: Key Considerations and Challenges; 4.2.3 Guido E Pieles and A Graham Stuart: The Athlete with Congenital Heart Disease; Section 5: Rhythm disorders of interest in sports cardiology; 5.1 Arthur Wilde and Nicole M Panhuyzen-Goedkoop: Channelopathy in Athletes; 5.2 Lluis Mont and Eduard Guasch: Ventricular Tachyarrythmias; 5.3 Mattias Wilhelm: Supraventricular tachyarrythmias; 5.4 Pietro Delise: Preexcitation and Conduction Abnormalities; Section 6: Sudden Cardiac Death in athletes; 6.1 Jonathan Drezner and Kimberly Harmon: Incidence of Sudden Cardiac Death in Athletes; 6.2 Cristina Basso and Gaetano Thiene: Cardiovascular causes of sudden death in athletes; 6.3 Paul Thompson: The Risk, Etiology, Clinical Features, Management & Prevention of Exercise-related Sudden Cardiac Death and Acute Cardiac Events in Adult Athletes; 6.4 - Less frequent causes of sudden cardiac death; 6.4.1 Erik Solberg and Paolo Adami: Less frequent causes of SCD (commotio cordis, aortic rupture). Non-cardiac causes (drug abuse, hyperpyrexia, rhabdomyolysis, sickle cell anemia, asthma, extreme environmental conditions (heat, cold, altitude) PART ONE; 6.4.2 Erik Solberg and Paolo Adami: Less frequent causes of SCD (commotio cordis, aortic rupture). Non-cardiac causes (drug abuse, hyperpyrexia, rhabdomyolysis, sickle cell anemia, asthma, extreme environmental conditions (heat, cold, altitude) PART TWO; 6.5 Domenico Corrado and Alessandro Zorzi: Preparticipation screening of young competitive athletes; 6.6 Luc Vanhees and Mats Borjesson: Cardiovascular screening in adult/senior competitive athletes; 6.7 Werner Budts, Massimo Chessa, and Javier Fernandex Sarabia: Cardiovascular screening of children and adolescent athletes; Section 7: Sports eligibility in athletes with cardiac abnormalities; 7.1 Antonio Pelliccia, Hein Heidbuchel, Domenico Corrado, Sanjay Sharma, and Mats Borjesson: Criteria and considerations relative to safe sport participation in athletes with cardiac abnormalities; Section 8: Excercise Prescription for cardiovascular health; 8.1 Massimo Piepoli, Mats Borjesson, and Mikael Dellborg: Criteria and considerations relative to safe sport participation in athletes with cardiac abnormalities; 8.2 Stephan Muller, Flavia Baldassarri, Julia Schonfeld, and Martin Halle: Monitoring exercise programs and improving CV performance; Section 9: Cardiac safety at sports facilities; 9.1 Mark Link and Mark Estes III: Resuscitation on the field: basic and advanced life support and automatic external defibrillators (AED); 9.2 Mats Borjesson, Luis Serratosa, and Efraim Kramer: Cardiac safety at sports events: the medical action plan; 9.3 Erik Solberg, Jakob Johansson, and Alessandro Biffi: Cardiac safety at fitness centres; Section 10: Cardiovascular effects of substance of abuse/doping; 10.1 Josef Niebauer and Carl-Johan Sundberg: World Anti-Doping Agency (WADA) and International Olympic Committee (IOC) list of prohibited substances and methods and their cardiovascular effects; 10.2 Ronald Maughan and SM Shirreffs: Nutrition and ergogenic aids prescription for competitive athletes; Section 11: Hypertension in athletes; 11.1 Stefano Caselli and Josef Niebauer: Diagnosis and management of hypertension in athletes

Trade Policy 买家须知